Evidence map›Paper›PMID 18184831›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2008

Design of mutant beta2 subunits as decoy molecules to reduce the expression of functional Ca2+ channels in cardiac cells.

Sabine Télémaque, Swapnil Sonkusare, Terrie Grain, Sung W Rhee, Joseph R Stimers, Nancy J Rusch, James D Marsh

Open access · greenAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Delivery of ion channel genes to treat cardiovascular diseases.Transactions of the American Clinical and Climatological Association · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sabine TélémaqueDivision of Cardiovascular Medicine, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham, #832, Little Rock, AR 72205, USA. stelemaque@uams.edu
Swapnil Sonkusare
Terrie Grain
Sung W Rhee
Joseph R Stimers
Nancy J Rusch
James D Marsh
University of Arkansas for Medical Sciences · US

Funding

UC Davis/NIH NeuroMab FacilityU24NS050606 · NINDS · UNIVERSITY OF CALIFORNIA DAVIS · PI TRIMMER, JAMES S · 2005 to 2014
$15.6M
Vascular Calcium Channel Expression in HypertensionR01HL064806 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI RUSCH, NANCY J · 2000 to 2012
$3.4M
Effect of Diet on Oxidative Stress, NO and HypertensionF32HL068406 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROBERTS, CHRISTIAN K · 2001 to 2003
$136k
NHLBI NIH HHS F32 HL068406NHLBI NIH HHS R01 HL-050818NHLBI NIH HHS R01 HL064806NHLBI NIH HHS R01 HL-68406NINDS NIH HHS U24 NS-050606NINDS NIH HHS U24 NS050606
6 · The paper itself

Abstract

Calcium influx through long-lasting ("L-type") Ca(2+) channels (Ca(V)) drives excitation-contraction in the normal heart. Dysregulation of this process contributes to Ca(2+) overload, and interventions that reduce expression of the pore-forming alpha(1) subunit may alleviate cytosolic Ca(2+) excess. As a molecular approach to disrupt the assembly of Ca(V)1.2 (alpha(1C)) channels at the cell membrane, we targeted the Ca(2+) channel beta(2) subunit, an intracellular chaperone that interacts with alpha(1C) via its beta interaction domain (BID) to promote Ca(V)1.2 channel expression. Recombinant adenovirus expressing either the full beta(2) subunit (Full-beta(2)) or truncated beta(2) subunit constructs lacking either the C terminus, N terminus, or both (N-BID, C-BID, and BID, respectively) fused to green fluorescent protein were developed as potential decoys and overexpressed in HL-1 cells. Fluorescence microscopy revealed that the localization of Full-beta(2) at the surface membrane was associated with increased Ca(2+) current mainly attributed to Ca(V)1.2 channels. In contrast, truncated N-BID and C-BID constructs showed punctate intracellular expression, and BID showed a diffuse cytosolic distribution. Total expression of the alpha(1C) protein of Ca(V)1.2 channels was similar between groups, but HL-1 cells overexpressing C-BID and BID exhibited reduced Ca(2+) current. C-BID and BID also attenuated Ca(2+) current associated with another L-type Ca(2+) channel, Ca(V)1.3, but they did not reduce transient Ca(2+) currents attributed to Ca(V)3 channels. These results suggest that beta(2) subunit mutants lacking the N terminus may preferentially disrupt the proper localization of L-type Ca(2+) channels in the cell membrane. Cardiac-specific delivery of these decoy molecules in vivo may represent a gene-based treatment for pathologies involving Ca(2+) overload.

Indexed as

Drug DesignMolecular MimicryMutationAnimalsCalciumCalcium Channels, L-TypeCell LineDNA, ComplementaryDown-RegulationDrug Delivery SystemsGenetic TherapyHumansMyocardiumProtein EngineeringProtein SubunitsRatsCalciumCalcium Channels, L-TypeDNA, ComplementaryProtein Subunits

Identifiers

PMID18184831
PMCPMC4939485
OpenAlexW2119026947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.